Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Peer Comparison
Company | LTP | Market Cap (in ₹ Cr) |
---|---|---|
Astal Laboratories Ltd | ₹97.15 | ₹95.50 |
Sun Pharmaceuticals Industries Ltd | ₹1,803.25 | ₹4,32,660.08 |
Divis Laboratories Ltd | ₹5,808.20 | ₹1,54,189.46 |
Cipla Ltd | ₹1,601.25 | ₹1,29,316.22 |
Mankind Pharma Ltd | ₹2,714.40 | ₹1,08,750.85 |
Torrent Pharmaceuticals Ltd | ₹3,186.35 | ₹1,07,835.72 |
22 Jul 2024
08 Jul 2024
29 Jun 2024
24 Jun 2024
21 May 2024
Financials
Profit and Loss
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 23.66 | 3.61 | 0.21 | 0.20 | 0.20 |
Total Expenses | 22.57 | 3.57 | 0.23 | 0.19 | 0.23 |
Profit Before Tax | 1.09 | 0.03 | -0.02 | 0.01 | -0.03 |
Profit After Tax | 0.78 | 0.02 | -0.02 | 0.01 | -0.03 |
Operating Profit after Depreciation | 1.10 | 0.03 | -0.02 | 0.01 | -0.03 |
Balance Sheet
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 0.69 | 0.01 | 0.01 | 0.05 | 0.07 |
Total Non Current Assets | 9.89 | 3.79 | 5.13 | 5.19 | 0.14 |
Total Current Assets | 26.73 | 6.11 | 0.10 | 0.11 | 5.13 |
TOTAL ASSETS | 36.61 | 9.91 | 5.23 | 5.31 | 5.27 |
Total Shareholder's Fund | 23.34 | 5.18 | 5.16 | 5.18 | 5.17 |
Cash Flow
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -5.59 | -1.44 | -0.25 | -0.19 | -0.20 |
Net Cash used in Investing Activities | -6.11 | 1.50 | 0.24 | 0.20 | 0.20 |
Net Cash used in Financing Activities | 17.69 | - | - | - | - |
Corporate Actions